XML 32 R22.htm IDEA: XBRL DOCUMENT v2.4.1.9
Segment, Customer and Geographical Reporting (Tables)
6 Months Ended
Mar. 31, 2015
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
The Company’s segment information for the three months ended March 31, 2015 and 2014 is summarized below:
 
Results of Operations for the Three Months Ended March 31,
2015
 
 
Contract
Research
 
 
Optics
 
 
Instruments
 
Biomedical
 
Total
 
Revenue
 
$
4,675,000
 
 
$
5,220,000
 
 
$
-
 
$
-
 
$
9,895,000
 
Gross Profit
 
 
1,952,000
 
 
 
1,808,000
 
 
 
-
 
 
-
 
 
3,760,000
 
GM %
 
 
41.8
%
 
 
34.6
%
 
 
-
 
 
-
 
 
38.0
%
SG&A
 
 
1,896,000
 
 
 
1,580,000
 
 
 
-
 
 
270,000
 
 
3,746,000
 
Gain on sale of assets
 
 
-
 
 
 
-
 
 
 
-
 
 
-
 
 
-
 
Operating Income (Loss)
 
 
56,000
 
 
 
228,000
 
 
 
-
 
 
(270,000)
 
 
14,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation and Amortization
 
 
74,000
 
 
 
204,000
 
 
 
-
 
 
15,000
 
 
293,000
 
Capital expenditures
 
 
4,000
 
 
 
152,000
 
 
 
-
 
 
56,000
 
 
212,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intangibles, Net
 
 
282,000
 
 
 
699,000
 
 
 
-
 
 
254,000
 
 
1,235,000
 
Goodwill
 
 
4,939,000
 
 
 
1,157,000
 
 
 
-
 
 
-
 
 
6,096,000
 
Total Assets
 
$
8,887,000
 
 
$
15,800,000
 
 
$
238,000
 
$
694,000
 
$
25,619,000
 
 
Results of Operations for the Three Months Ended March 31,
2014
 
 
Contract
Research
 
 
Optics
 
 
Instruments
 
Biomedical
 
 
Total
 
Revenue
 
$
5,614,000
 
 
$
4,789,000
 
 
$
-
 
$
4,000
 
 
$
10,407,000
 
Gross Profit
 
 
2,442,000
 
 
 
1,919,000
 
 
 
(6,000)
 
 
4,000
 
 
 
4,359,000
 
GM %
 
 
43.5
%
 
 
40.1
%
 
 
-
 
 
100.0
%
 
 
41.9
%
SG&A
 
 
2,200,000
 
 
 
1,397,000
 
 
 
70,000
 
 
225,000
 
 
 
3,892,000
 
Gain on sale of assets
 
 
-
 
 
 
-
 
 
 
-
 
 
-
 
 
 
-
 
Operating Income (Loss)
 
 
242,000
 
 
 
522,000
 
 
 
(76,000)
 
 
(221,000)
 
 
 
467,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation and Amortization
 
 
70,000
 
 
 
183,000
 
 
 
-
 
 
15,000
 
 
 
268,000
 
Capital expenditures
 
 
12,000
 
 
 
397,000
 
 
 
-
 
 
-
 
 
 
409,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intangibles, Net
 
 
316,000
 
 
 
858,000
 
 
 
-
 
 
148,000
 
 
 
1,322,000
 
Goodwill
 
 
4,939,000
 
 
 
1,333,000
 
 
 
-
 
 
-
 
 
 
6,272,000
 
Total Assets
 
$
10,230,000
 
 
$
13,816,000
 
 
$
455,000
 
$
332,000
 
 
$
24,833,000
 
 
The Company’s segment information for the six months ended March 31, 2015 and 2014 is summarized below:
 
Results of Operations for the Six Months Ended March 31,
2015
 
 
Contract
Research
 
 
Optics
 
 
Instruments
 
Biomedical
 
Total
 
Revenue
 
$
9,338,000
 
 
$
10,168,000
 
 
$
-
 
$
-
 
$
19,506,000
 
Gross Profit
 
 
4,050,000
 
 
 
3,302,000
 
 
 
-
 
 
-
 
 
7,352,000
 
GM %
 
 
43.4
%
 
 
32.5
%
 
 
-
 
 
-
 
 
37.7
%
SG&A
 
 
3,778,000
 
 
 
3,670,000
 
 
 
-
 
 
504,000
 
 
7,952,000
 
Gain on sale of assets
 
 
-
 
 
 
(185,000)
 
 
 
-
 
 
-
 
 
(185,000)
 
Operating Income (Loss)
 
 
272,000
 
 
 
(183,000)
 
 
 
-
 
 
(504,000)
 
 
(415,000)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation and Amortization
 
 
148,000
 
 
 
408,000
 
 
 
-
 
 
30,000
 
 
586,000
 
Capital expenditures
 
 
4,000
 
 
 
396,000
 
 
 
-
 
 
56,000
 
 
456,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intangibles, Net
 
 
282,000
 
 
 
699,000
 
 
 
-
 
 
254,000
 
 
1,235,000
 
Goodwill
 
 
4,939,000
 
 
 
1,157,000
 
 
 
-
 
 
-
 
 
6,096,000
 
Total Assets
 
$
8,887,000
 
 
$
15,800,000
 
 
$
238,000
 
$
694,000
 
$
25,619,000
 
 
Results of Operations for the Six Months Ended March 31,
2014
 
 
Contract
Research
 
 
Optics
 
 
Instruments
 
 
Biomedical
 
 
Total
 
Revenue
 
$
11,454,000
 
 
$
8,887,000
 
 
$
773,000
 
 
$
4,000
 
 
$
21,118,000
 
Gross Profit
 
 
4,971,000
 
 
 
3,517,000
 
 
 
317,000
 
 
 
4,000
 
 
 
8,809,000
 
GM %
 
 
43.4
%
 
 
39.6
%
 
 
41.0
%
 
 
100.0
%
 
 
41.7
%
SG&A
 
 
4,381,000
 
 
 
2,596,000
 
 
 
539,000
 
 
 
399,000
 
 
 
7,915,000
 
Gain on sale of assets
 
 
-
 
 
 
-
 
 
 
(1,187,000)
 
 
 
-
 
 
 
(1,187,000)
 
Operating Income (Loss)
 
 
590,000
 
 
 
921,000
 
 
 
965,000
 
 
 
(395,000)
 
 
 
2,081,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation and Amortization
 
 
139,000
 
 
 
362,000
 
 
 
2,000
 
 
 
32,000
 
 
 
535,000
 
Capital expenditures
 
 
12,000
 
 
 
527,000
 
 
 
-
 
 
 
-
 
 
 
539,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intangibles, Net
 
 
316,000
 
 
 
858,000
 
 
 
-
 
 
 
148,000
 
 
 
1,322,000
 
Goodwill
 
 
4,939,000
 
 
 
1,333,000
 
 
 
-
 
 
 
-
 
 
 
6,272,000
 
Total Assets
 
$
10,230,000
 
 
$
13,816,000
 
 
$
455,000
 
 
$
332,000
 
 
$
24,833,000
 
Schedule Of Segment Revenue By Geographical Location [Table Text Block]
Revenue by geographic location in total and as a percentage of total revenue, for the three months ended March 31, 2015 and 2014 are as follows:
 
 
 
Three Months Ended
 
 
Three Months Ended
 
 
 
March 31, 2015
 
 
March 31, 2014
 
Geographic Location
 
Revenue
 
% of Total
 
 
Revenue
 
% of Total
 
United States
 
$
7,982,000
 
81
%
 
$
8,622,000
 
83
%
Europe
 
 
1,124,000
 
11
%
 
 
845,000
 
8
%
Other
 
 
789,000
 
8
%
 
 
940,000
 
9
%
 
 
$
9,895,000
 
100
%
 
$
10,407,000
 
100
%
 
Revenue by geographic location in total and as a percentage of total revenue, for the six months ended March 31, 2015 and 2014 are as follows:
 
 
 
Six Months Ended
 
 
Six Months Ended
 
 
 
March 31, 2015
 
 
March 31, 2014
 
Geographic Location
 
Revenue
 
% of Total
 
 
Revenue
 
% of Total
 
United States
 
$
15,664,000
 
80
%
 
$
17,529,000
 
83
%
Europe
 
 
2,008,000
 
10
%
 
 
1,675,000
 
8
%
Other
 
 
1,834,000
 
10
%
 
 
1,914,000
 
9
%
 
 
$
19,506,000
 
100
%
 
$
21,118,000
 
100
%